Pharvaris (PHVS): Focused Pipeline On Hereditary Angioedema
Extreme Media Pharvaris (NASDAQ:PHVS) is a company very focused on developing therapies for all sub-types of hereditary angioedema (HAE’). Their pipeline looks like this: Pharvaris pipeline (Pharvaris website) This is something new; although there are […]
